Can freezing kill lung cancer? new study tests cryodevitalization
NCT ID NCT06593106
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests a procedure called cryodevitalization, which uses a flexible probe to freeze and kill early-stage lung cancer cells. It is done during a standard biopsy. The goal is to find the safest freezing time and see if the treatment is tolerable for 30 patients with stage I or II lung cancer.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for STAGE I LUNG CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Vanderbilt University/Ingram Cancer Center
RECRUITINGNashville, Tennessee, 37203, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.